Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android:
Available for Mac and Windows Desktops and laptops:
- Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS. [JOURNAL ARTICLE]
- Neurol Neuroimmunol Neuroinflamm 2015 Dec; 2(6):e176.
- Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes. [REVIEW, JOURNAL ARTICLE]
- Ther Adv Neurol Disord 2015 Nov; 8(6):274-293.
- Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis. [Journal Article]
- BMC Neurol 2015; 15(1):240.
- Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients. [JOURNAL ARTICLE]
- Mult Scler 2015 Nov 12.
- Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial. [Journal Article]
- BMC Neurol 2015.:232.
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. [Clinical Trial, Phase III, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
- N Engl J Med 2015 Oct 8; 373(15):1418-28.
- [TERIFLUNOMIDE: A NEW ORAL IMMUNOMODULATING AGENT FOR MULTIPLE SCLEROSIS]. [English Abstract, Journal Article, Review]
- Ideggyogy Sz 2015 Mar 30; 68(3-4):79-87.
- Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies. [Journal Article]
- BMC Pharmacol Toxicol 2015; 16(1):25.
- The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada. [JOURNAL ARTICLE]
- J Med Econ 2015 Sep 21.:1-7.